Parameter 1: path of XML files
/Users/robertatakenaka/github.com/scieloorg/PC-Programs/src/scielo/bin/PMCXMLTools/converter
Parameter 2: supplementary XML

Parameter 3: output path
/Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base
Parameter 4: database name (no extension)
v49n1
Parameter 5: batch and shell script filename to generate .mst database name (no extension)
v49n1
Parameter 6: cisis path
/Users/robertatakenaka/Documents/vm_dados/dados_pmc/cisis
Parameter 7: debug_depth
0
Parameter 8: display messages on screen? yes|no
no
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-01-0005.id?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-01-0005.id
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-1-1.id?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-1-1.id
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-1-19.id?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-1-19.id
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-1-35.id?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-1-35.id
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-1-41.id?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-1-41.id
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-1-5.id?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-1-5.id
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-1-52.id?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-1-52.id
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-1-89.id?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-1-89.id
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-1-9.id?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-1-9.id
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-19.id?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-19.id
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-28.id?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-28.id
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-5.id?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-5.id
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-56.id?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-56.id
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-77.id?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-77.id
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-82.id?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-82.id
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-9.id?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/0004-2803-ag-49-9.id
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/id2mst.bat?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/temp.mst?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/temp.mst
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/temp.xrf?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/temp.xrf
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/v49n1.bat?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/v49n1.mst?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/v49n1.mst
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/v49n1.sh?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/v49n1.xrf?
deleting /Users/robertatakenaka/Documents/vm_dados/dados_pmc/ag/v49n1/pmc/pmc_base/v49n1.xrf
"{ 'doc' : {'h':{'71':'research-article','40':'en','030':'Arq. Gastroenterol.','49':'ORIGINAL ARTICLE','085':[{'l':'en','k':['Polymorphysm, genetic','Hepatitis C, chronic','Ferritins','Interferons']},{'l':'pt','k':['Polimorfismo gen\u00e9tico','Hepatite C cr\u00f4nica','Ferritinas','Interferons']}],'010':[{'n':'Silvia','s':'Coelho-Borges','r':'ND'},{'n':'Hugo','s':'Cheinquer','r':'ND','1':''},{'n':'Fernando Herz','s':'Wolff','r':'ND','1':''},{'n':'Nelson','s':'Cheinquer','r':'ND','1':''},{'n':'Luciano','s':'Krug','r':'ND','1':''},{'n':'Patricia','s':'Ashton-Prolla','r':'ND','1':''}],'012':{'t':'Effect of HFE gene polymorphism on sustained virological response in patients with chronic hepatitis C and elevated serum ferritin','l':'en'},'012':{'t':'Efeito do polimorfismo do gene HFE sobre a resposta viral sustentada em portadores de hepatite cr\u00f4nica C com ferritina s\u00e9rica elevada','l':'pt'},'031':'49','032':'1','035':'0004-2803','064':'Jan-Mar','065':'2012','014':{'f':'9','l':'13'},'120':'9','070':[{'i':'aff1','Gastroenterology Department, Hospital de Cl\u00ednicas de Porto Alegre'},{'i':'aff2','National Institute of Science and Technology for Health Technology Assessment (IATS) CNPq/Brazil'},{'i':'aff3','Amplicon - Molecular Biology Laboratory'},{'i':'aff4','Medical Genetics Service, Hospital de Cl\u00ednicas de Porto Alegre'},{'i':'aff5','Genetics Department, UFRGS, Porto Alegre, RS, Brasil'}],'72':'37','083':{'a':'<p>\n               <bold>CONTEXT</bold>: Abnormal serum ferritin levels are found in approximately 20%-30% of the patients with chronic hepatitis C and are associated with a lower response rate to interferon therapy. <bold>OBJECTIVE</bold>: To determine if the presence of HFE gene mutations had any effect on the sustained virological response rate to interferon based therapy in chronic hepatitis C patients with elevated serum ferritin. <bold>METHODS</bold>: A total of 44 treatment na&#207;ve patients with histologically demonstrated chronic hepatitis C, all infected with hepatitis C virus genotype non-1 (38 genotype 3; 6 genotype 2) and serum ferritin above 500 ng/mL were treated with interferon (3 MU, 3 times a week) and ribavirin (1.000 mg, daily) for 24 weeks. <bold>RESULTS</bold>: Sustained virological response was defined as negative qualitative HCV-RNA more than 24 weeks after the end of treatment. Serum HCV-RNA was measured by qualitative in house polymerase chain reaction with a limit of detection of 200 IU/mL. HFE gene mutation was detected using restriction-enzyme digestion with RsaI (C282Y mutation analysis) and BclI (H63D mutation analysis) in 16 (37%) patients, all heterozygous (11 H63D, 2 C282Y and 3 both). Sustained virological response was achieved in 0 of 16 patients with HFE gene mutations and 11 (41%) of 27 patients without HFE gene mutations (<italic>P</italic> = 0.002; exact Fisher test). <bold>CONCLUSION</bold>: Heterozigozity for H63D and/or C282Y HFE gene mutation predicts absence of sustained virological response to combination treatment with interferon and ribavirin in patients with chronic hepatitis C, non-1 genotype and serum ferritin levels above 500 ng/mL.</p>','l':'en'},'83':{'a':'<p>\n               <bold>CONTEXTO</bold>: N&#237;veis s&#233;ricos anormais de ferritina s&#227;o encontrados em aproximadamente 20%-30% dos pacientes com hepatite cr&#244;nica C e est&#227;o associadas a uma baixa taxa de resposta &#224; terapia com interferon. <bold>OBJETIVO</bold>: Avaliar a associa&#231;&#227;o entre a presen&#231;a de muta&#231;&#245;es do gene HFE e a taxa de resposta virol&#243;gica sustentada ao interferon em pacientes portadores de hepatite cr&#244;nica C com ferritina s&#233;rica elevada. <bold>M&#201;TODOS</bold>: Um total de 44 pacientes, virgem de tratamento, infectado pelo v&#237;rus da hepatite C de gen&#243;tipos n&#227;o-1 (38 gen&#243;tipo 3; 6 gen&#243;tipo 2) e ferritina s&#233;rica acima de 500 ng/mL foi tratado com interferon (3 MU, tr&#234;s vezes por semana) e ribavirina (1000 mg/dia) por 24 semanas. Resposta virol&#243;gica sustentada foi definida como HCV-RNA indetect&#225;vel 24 semanas ap&#243;s o fim do tratamento. Foi utilizado t&#233;cnica de rea&#231;&#227;o em cadeia da polimerase em tempo-real com limite de detec&#231;&#227;o de 200 UI /mL. <bold>RESULTADOS</bold>: Muta&#231;&#245;es do gene HFE foram detectadas por \"restriction-enzyme digestion\" com RsaI (an&#225;lise de muta&#231;&#227;o C282Y) e BclI (an&#225;lise de muta&#231;&#227;o H63D) em 16 pacientes (37%), todos heterozigotos (11 H63D, 2 C282Y e 3 ambos). Resposta virol&#243;gica sustentada foi alcan&#231;ada em 0 de 16 pacientes com muta&#231;&#245;es do gene HFE e 11 (41%) dos 27 pacientes sem muta&#231;&#245;es do gene HFE (P = 0,002; teste exato de Fisher). <bold>CONCLUS&#195;O</bold>: A heterozigose para os genes H63D e/ou C282Y HFE est&#225; associada &#224; redu&#231;&#227;o significativa da taxa de resposta virol&#243;gica sustentada ao tratamento com interferon e ribavirina em pacientes com hepatite cr&#244;nica C, gen&#243;tipo n&#227;o-1 e com n&#237;veis s&#233;ricos de ferritina acima de 500 ng/mL.</p>','l':'pt'},'111':'2011','04','25','112':'2011','04','25','113':'2011','08','10','114':'2011','08','10'},'r':[{'071':'journal','012':{'t':'[Interferon-alpha and ribavirin therapy on chronic hepatitis C virus infection: the experience of Rio Grande do Sul State Health Department, Brazil]','l':'en'},'30':'Arq Gastroenterol','10':[{'n':'AV','s':'Alves','r':'ND'},{'n':'AP','s':'de Azevedo','r':'ND'},{'n':'C','s':'Perin','r':'ND'},{'n':'GZ','s':'Ramos','r':'ND'},{'n':'AB','s':'Brand\u00e3o','r':'ND'},{'n':'AA','s':'de Mattos','r':'ND'},{'n':'PR','s':'de Almeida','r':'ND'}],'31':'40','64':'2003','65':'2003','14':{'f':'227','l':'227'},'118':'1'},{'071':'','012':{'t':'Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C','l':'en'},'30':'J Hepatol','10':[{'n':'NK','s':'Beinker','r':'ND'},{'n':'MD','s':'Voigt','r':'ND'},{'n':'M','s':'Arendse','r':'ND'},{'n':'J','s':'Smit','r':'ND'},{'n':'IA','s':'Stander','r':'ND'},{'n':'RE','s':'Kirsch','r':'ND'}],'31':'25','64':'1996','65':'1996','14':{'f':'633','l':'633'},'118':'2'},{'071':'','012':{'t':'Iron and chronic viral hepatitis','l':'en'},'30':'Hepatology','10':[{'n':'HL','s':'Bonkovsky','r':'ND'},{'n':'BF','s':'Banner','r':'ND'},{'n':'AL','s':'Rothman','r':'ND'}],'31':'25','64':'1997','65':'1997','14':{'f':'759','l':'759'},'118':'3'},{'071':'','012':{'t':'Iron as a comorbid factor in chronic viral hepatitis','l':'en'},'30':'Am J Gastroenterol','10':{'n':'HL','s':'Bonkovsky','r':'ND'},'31':'97','64':'2002','65':'2002','14':{'f':'1','l':'1'},'118':'4'},{'071':'','012':{'t':'Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C','l':'en'},'30':'J Hepatol','10':[{'n':'HL','s':'Bonkovsky','r':'ND'},{'n':'N','s':'Troy','r':'ND'},{'n':'K','s':'McNeal','r':'ND'},{'n':'BF','s':'Banner','r':'ND'},{'n':'A','s':'Sharma','r':'ND'},{'n':'J','s':'Obando','r':'ND'},{'n':'S','s':'Mehta','r':'ND'},{'n':'RS','s':'Koff','r':'ND'},{'n':'Q','s':'Liu','r':'ND'},{'n':'CC','s':'Hsieh','r':'ND'}],'31':'37','64':'2002','65':'2002','14':{'f':'848','l':'848'},'118':'5'},{'071':'','012':{'t':'Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C','l':'en'},'30':'Gastroenterology','10':[{'n':'HL','s':'Bonkovsky','r':'ND'},{'n':'D','s':'Naishadham','r':'ND'},{'n':'RW','s':'Lambrecht','r':'ND'},{'n':'RT','s':'Chung','r':'ND'},{'n':'JC','s':'Hoefs','r':'ND'},{'n':'SR','s':'Nash','r':'ND'},{'n':'TE','s':'Rogers','r':'ND'},{'n':'BF','s':'Banner','r':'ND'},{'n':'RK','s':'Sterling','r':'ND'},{'n':'JA','s':'Donovan','r':'ND'},{'n':'RJ','s':'Fontana','r':'ND'},{'n':'AM','s':'Di Bisceglie','r':'ND'},{'n':'MG','s':'Ghany','r':'ND'},{'n':'C','s':'Morishima','r':'ND'}],'31':'131','64':'2006','65':'2006','14':{'f':'1440','l':'1440'},'118':'6'},{'071':'','18':'Portaria 34 de 28 de setembro de 2007. Disp\u00f5e sobre protocolo cl\u00ednico e diretrizes terap\u00eauticas para hepatite viral C','62':'Minist\u00e9rio da Sa\u00fade','64':'2007','65':'2007','66':'Bras\u00edlia','118':'7'},{'071':'','012':{'t':'The H63D genetic variant of the HFE gene is independently associated with the virological response to interferon and ribavirin therapy in chronic hepatitis C','l':'en'},'30':'Eur J Gastroenterol Hepatol','10':[{'n':'MV','s':'Carneiro','r':'ND'},{'n':'FF','s':'Souza','r':'ND'},{'n':'AC','s':'Teixeira','r':'ND'},{'n':'JF','s':'Figueiredo','r':'ND'},{'n':'MG','s':'Villanova','r':'ND'},{'n':'M','s':'Secaf','r':'ND'},{'n':'AD','s':'Passos','r':'ND'},{'n':'LN','s':'Ramalho','r':'ND'},{'n':'FP','s':'Carneiro','r':'ND'},{'n':'S','s':'Zucoloto','r':'ND'},{'n':'AL','s':'Candolo Martinelli','r':'ND'}],'31':'22','64':'2010','65':'2010','14':{'f':'1204','l':'1204'},'118':'8'},{'071':'','012':{'t':'HCV genotype 3: an independent predictor of fibrosis progression in chronic hepatitis C','l':'en'},'30':'J Hepatol','10':[{'n':'S','s':'De Nicola','r':'ND'},{'n':'A','s':'Aghemo','r':'ND'},{'n':'MG','s':'Rumi','r':'ND'},{'n':'M','s':'Colombo','r':'ND'}],'31':'51','64':'2009','65':'2009','14':{'f':'964','l':'964'},'118':'9'},{'071':'','012':{'t':'Measurements of iron status in patients with chronic hepatitis','l':'en'},'30':'Gastroenterology','10':[{'n':'AM','s':'Di Bisceglie','r':'ND'},{'n':'CA','s':'Axiotis','r':'ND'},{'n':'JH','s':'Hoofnagle','r':'ND'},{'n':'BR','s':'Bacon','r':'ND'}],'31':'102','64':'1992','65':'1992','14':{'f':'2108','l':'2108'},'118':'10'},{'071':'','012':{'t':'Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial','l':'en'},'30':'Hepatology','10':[{'n':'AM','s':'Di Bisceglie','r':'ND'},{'n':'HL','s':'Bonkovsky','r':'ND'},{'n':'S','s':'Chopra','r':'ND'},{'n':'S','s':'Flamm','r':'ND'},{'n':'RK','s':'Reddy','r':'ND'},{'n':'N','s':'Grace','r':'ND'},{'n':'P','s':'Killenberg','r':'ND'},{'n':'C','s':'Hunt','r':'ND'},{'n':'C','s':'Tamburro','r':'ND'},{'n':'AS','s':'Tavill','r':'ND'},{'n':'R','s':'Ferguson','r':'ND'},{'n':'E','s':'Krawitt','r':'ND'},{'n':'B','s':'Banner','r':'ND'},{'n':'BR','s':'Bacon','r':'ND'}],'31':'32','64':'2000','65':'2000','14':{'f':'135','l':'135'},'118':'11'},{'071':'','012':{'t':'Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection','l':'en'},'30':'Liver','10':[{'n':'S','s':'Distante','r':'ND'},{'n':'K','s':'Bj\u00d8ro','r':'ND'},{'n':'KB','s':'Hellum','r':'ND'},{'n':'B','s':'Myrvang','r':'ND'},{'n':'JP','s':'Berg','r':'ND'},{'n':'K','s':'Skaug','r':'ND'},{'n':'N','s':'Raknerud','r':'ND'},{'n':'H','s':'Bell','r':'ND'}],'31':'22','64':'2002','65':'2002','14':{'f':'269','l':'269'},'118':'12'},{'071':'','012':{'t':'A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis','l':'en'},'30':'Nat Genet','10':[{'n':'JN','s':'Feder','r':'ND'},{'n':'A','s':'Gnirke','r':'ND'},{'n':'W','s':'Thomas','r':'ND'},{'n':'Z','s':'Tsuchihashi','r':'ND'},{'n':'DA','s':'Ruddy','r':'ND'},{'n':'A','s':'Basava','r':'ND'},{'n':'F','s':'Dormishian','r':'ND'},{'n':'R Jr','s':'Domingo','r':'ND'},{'n':'MC','s':'Ellis','r':'ND'},{'n':'A','s':'Fullan','r':'ND'},{'n':'LM','s':'Hinton','r':'ND'},{'n':'NL','s':'Jones','r':'ND'},{'n':'BE','s':'Kimmel','r':'ND'},{'n':'GS','s':'Kronmal','r':'ND'},{'n':'P','s':'Lauer','r':'ND'},{'n':'VK','s':'Lee','r':'ND'},{'n':'DB','s':'Loeb','r':'ND'},{'n':'FA','s':'Mapa','r':'ND'},{'n':'E','s':'McClelland','r':'ND'},{'n':'NC','s':'Meyer','r':'ND'},{'n':'GA','s':'Mintier','r':'ND'},{'n':'N','s':'Moeller','r':'ND'},{'n':'T','s':'Moore','r':'ND'},{'n':'E','s':'Morikang','r':'ND'},{'n':'CE','s':'Prass','r':'ND'},{'n':'L','s':'Quintana','r':'ND'},{'n':'SM','s':'Starnes','r':'ND'},{'n':'RC','s':'Schatzman','r':'ND'},{'n':'KJ','s':'Brunke','r':'ND'},{'n':'DT','s':'Drayna','r':'ND'},{'n':'NJ','s':'Risch','r':'ND'},{'n':'BR','s':'Bacon','r':'ND'},{'n':'RK','s':'Wolff','r':'ND'}],'31':'13','64':'1996','65':'1996','14':{'f':'399','l':'399'},'118':'13'},{'071':'','012':{'t':'Predictors of response to therapy for chronic hepatitis C','l':'en'},'30':'Semin Liver Dis','10':{'n':'P','s':'Ferenci','r':'ND'},'31':'24','64':'2004','65':'2004','14':{'f':'25','l':'25'},'118':'14'},{'071':'','012':{'t':'Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection','l':'en'},'30':'N Engl J Med','10':[{'n':'MW','s':'Fried','r':'ND'},{'n':'ML','s':'Shiffman','r':'ND'},{'n':'KR','s':'Reddy','r':'ND'},{'n':'C','s':'Smith','r':'ND'},{'n':'G','s':'Marinos','r':'ND'},{'n':'FL Jr','s':'Gon\u00e7ales','r':'ND'},{'n':'D','s':'H\u00e4ussinger','r':'ND'},{'n':'M','s':'Diago','r':'ND'},{'n':'G','s':'Carosi','r':'ND'},{'n':'D','s':'Dhumeaux','r':'ND'},{'n':'A','s':'Craxi','r':'ND'},{'n':'A','s':'Lin','r':'ND'},{'n':'J','s':'Hoffman','r':'ND'},{'n':'J','s':'Yu','r':'ND'}],'31':'347','64':'2002','65':'2002','14':{'f':'975','l':'975'},'118':'15'},{'071':'','012':{'t':'Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C','l':'en'},'30':'J Gastroenterol Hepatol','10':[{'n':'N','s':'Fujita','r':'ND'},{'n':'R','s':'Sugimoto','r':'ND'},{'n':'N','s':'Urawa','r':'ND'},{'n':'J','s':'Araki','r':'ND'},{'n':'R','s':'Mifuji','r':'ND'},{'n':'M','s':'Yamamoto','r':'ND'},{'n':'S','s':'Horiike','r':'ND'},{'n':'H','s':'Tanaka','r':'ND'},{'n':'M','s':'Iwasa','r':'ND'},{'n':'Y','s':'Kobayashi','r':'ND'},{'n':'Y','s':'Adachi','r':'ND'},{'n':'M','s':'Kaito','r':'ND'}],'31':'22','64':'2007','65':'2007','14':{'f':'1886','l':'1886'},'118':'16'},{'071':'','012':{'t':'Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection','l':'en'},'30':'Hepatology','10':[{'n':'MJ','s':'Fuller','r':'ND'},{'n':'NH','s':'Shoukry','r':'ND'},{'n':'T','s':'Gushima','r':'ND'},{'n':'DG','s':'Bowen','r':'ND'},{'n':'B','s':'Callendret','r':'ND'},{'n':'KJ','s':'Campbell','r':'ND'},{'n':'DL','s':'Hasselschwert','r':'ND'},{'n':'AL','s':'Hughes','r':'ND'},{'n':'CM','s':'Walker','r':'ND'}],'31':'51','64':'2010','65':'2010','14':{'f':'378','l':'378'},'118':'17'},{'071':'','012':{'t':'Hereditary haemochromatosis as an immunological disease','l':'en'},'30':'Br J Haematol','10':[{'n':'GS','s':'Gerhard','r':'ND'},{'n':'AE','s':'Ten Elshof','r':'ND'},{'n':'MJ','s':'Chorney','r':'ND'}],'31':'100','64':'1998','65':'1998','14':{'f':'247','l':'247'},'118':'18'},{'071':'','012':{'t':'HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy','l':'en'},'30':'Gut','10':[{'n':'CN','s':'Hayes','r':'ND'},{'n':'M','s':'Kobayashi','r':'ND'},{'n':'N','s':'Akuta','r':'ND'},{'n':'F','s':'Suzuki','r':'ND'},{'n':'H','s':'Kumada','r':'ND'},{'n':'H','s':'Abe','r':'ND'},{'n':'D','s':'Miki','r':'ND'},{'n':'M','s':'Imamura','r':'ND'},{'n':'H','s':'Ochi','r':'ND'},{'n':'N','s':'Kamatani','r':'ND'},{'n':'Y','s':'Nakamura','r':'ND'},{'n':'K','s':'Chayama','r':'ND'}],'31':'60','64':'2011','65':'2011','14':{'f':'261','l':'261'},'118':'19'},{'071':'','012':{'t':'The epidemiology of hyperferritinaemia','l':'en'},'30':'World J Gastroenterol','10':[{'n':'S','s':'Hearnshaw','r':'ND'},{'n':'NP','s':'Thompson','r':'ND'},{'n':'A','s':'McGill','r':'ND'}],'31':'12','64':'2006','65':'2006','14':{'f':'5866','l':'5866'},'118':'20'},{'071':'','012':{'t':'Iron depletion is not effective in inducing a virologic response in patients with chronic hepatitis C who failed to respond to interferon therapy','l':'en'},'30':'Am J Gastroenterol','10':{'n':'JL','s':'Herrera','r':'ND'},'31':'94','64':'1999','65':'1999','14':{'f':'3571','l':'3571'},'118':'21'},{'071':'','012':{'t':'Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions','l':'en'},'30':'J Hepatol','10':[{'n':'C','s':'H\u00e9zode','r':'ND'},{'n':'C','s':'Cazeneuve','r':'ND'},{'n':'O','s':'Cou\u00e9','r':'ND'},{'n':'F','s':'Roudot-Thoraval','r':'ND'},{'n':'I','s':'Lonjon','r':'ND'},{'n':'A','s':'Bastie','r':'ND'},{'n':'C','s':'Duvoux','r':'ND'},{'n':'JM','s':'Pawlotsky','r':'ND'},{'n':'ES','s':'Zafrani','r':'ND'},{'n':'S','s':'Amselem','r':'ND'},{'n':'D','s':'Dhumeaux','r':'ND'}],'31':'31','64':'1999','65':'1999','14':{'f':'979','l':'979'},'118':'22'},{'071':'','012':{'t':'Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C','l':'en'},'30':'J Hepatol','10':[{'n':'H','s':'Hofer','r':'ND'},{'n':'C','s':'Osterreicher','r':'ND'},{'n':'W','s':'Jessner','r':'ND'},{'n':'M','s':'Penz','r':'ND'},{'n':'P','s':'Steindl-Munda','r':'ND'},{'n':'F','s':'Wrba','r':'ND'},{'n':'P','s':'Ferenci','r':'ND'}],'31':'40','64':'2004','65':'2004','14':{'f':'1018','l':'1018'},'118':'23'},{'071':'','012':{'t':'The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C','l':'en'},'30':'Gastroenterology','10':[{'n':'L','s':'Kazemi-Shirazi','r':'ND'},{'n':'C','s':'Datz','r':'ND'},{'n':'T','s':'Maier-Dobersberger','r':'ND'},{'n':'K','s':'Kaserer','r':'ND'},{'n':'F','s':'Hackl','r':'ND'},{'n':'C','s':'Polli','r':'ND'},{'n':'PE','s':'Steindl','r':'ND'},{'n':'E','s':'Penner','r':'ND'},{'n':'P','s':'Ferenci','r':'ND'}],'31':'116','64':'1999','65':'1999','14':{'f':'127','l':'127'},'118':'24'},{'071':'','012':{'t':'Influence of HFE gene polymorphism on the progression and treatment of chronic hepatitis C','l':'en'},'30':'J Viral Hepat','10':[{'n':'P','s':'Lebray','r':'ND'},{'n':'H','s':'Zylberberg','r':'ND'},{'n':'S','s':'Hue','r':'ND'},{'n':'B','s':'Poulet','r':'ND'},{'n':'F','s':'Carnot','r':'ND'},{'n':'S','s':'Martin','r':'ND'},{'n':'Y','s':'Chretien','r':'ND'},{'n':'S','s':'Pol','r':'ND'},{'n':'S','s':'Caillat-Zuckman','r':'ND'},{'n':'C','s':'Br\u00e9chot','r':'ND'},{'n':'B','s':'Nalpas','r':'ND'}],'31':'11','64':'2004','65':'2004','14':{'f':'175','l':'175'},'118':'25'},{'071':'','012':{'t':'An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response','l':'en'},'30':'Gastroenterology','10':[{'n':'A','s':'Mangia','r':'ND'},{'n':'AJ','s':'Thompson','r':'ND'},{'n':'R','s':'Santoro','r':'ND'},{'n':'V','s':'Piazzolla','r':'ND'},{'n':'HL','s':'Tillmann','r':'ND'},{'n':'K','s':'Patel','r':'ND'},{'n':'KV','s':'Shianna','r':'ND'},{'n':'L','s':'Mottola','r':'ND'},{'n':'D','s':'Petruzzellis','r':'ND'},{'n':'D','s':'Bacca','r':'ND'},{'n':'V','s':'Carretta','r':'ND'},{'n':'N','s':'Minerva','r':'ND'},{'n':'DB','s':'Goldstein','r':'ND'},{'n':'JG','s':'McHutchison','r':'ND'}],'31':'139','64':'2010','65':'2010','14':{'f':'821','l':'821'},'118':'26'},{'071':'','012':{'t':'Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial','l':'en'},'30':'Lancet','10':[{'n':'MP','s':'Manns','r':'ND'},{'n':'JG','s':'McHutchison','r':'ND'},{'n':'SC','s':'Gordon','r':'ND'},{'n':'VK','s':'Rustgi','r':'ND'},{'n':'M','s':'Shiffman','r':'ND'},{'n':'R','s':'Reindollar','r':'ND'},{'n':'ZD','s':'Goodman','r':'ND'},{'n':'K','s':'Koury','r':'ND'},{'n':'M','s':'Ling','r':'ND'},{'n':'JK','s':'Albrecht','r':'ND'}],'31':'358','64':'2001','65':'2001','14':{'f':'958','l':'958'},'118':'27'},{'071':'','012':{'t':'Host and viral factors contributing to CD8+ T cell failure in hepatitis C virus infection','l':'en'},'30':'World J Gastroenterol','10':[{'n':'C','s':'Neumann-Haefelin','r':'ND'},{'n':'HC','s':'Spangenberg','r':'ND'},{'n':'HE','s':'Blum','r':'ND'},{'n':'R','s':'Thimme','r':'ND'}],'31':'13','64':'2007','65':'2007','14':{'f':'4839','l':'4839'},'118':'28'},{'071':'','012':{'t':'Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection','l':'en'},'30':'J Interferon Cytokine Res','10':[{'n':'S','s':'Pianko','r':'ND'},{'n':'JG','s':'McHutchison','r':'ND'},{'n':'SC','s':'Gordon','r':'ND'},{'n':'S','s':'Heaton','r':'ND'},{'n':'ZD','s':'Goodman','r':'ND'},{'n':'K','s':'Patel','r':'ND'},{'n':'CM','s':'Cortese','r':'ND'},{'n':'EM','s':'Brunt','r':'ND'},{'n':'BR','s':'Bacon','r':'ND'},{'n':'LM','s':'Blatt','r':'ND'}],'31':'22','64':'2002','65':'2002','14':{'f':'483','l':'483'},'118':'29'},{'071':'','012':{'t':'Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study','l':'en'},'30':'Gastroenterology','10':[{'n':'A','s':'Rauch','r':'ND'},{'n':'Z','s':'Kutalik','r':'ND'},{'n':'P','s':'Descombes','r':'ND'},{'n':'T','s':'Cai','r':'ND'},{'n':'J','s':'Di Iulio','r':'ND'},{'n':'T','s':'Mueller','r':'ND'},{'n':'M','s':'Bochud','r':'ND'},{'n':'M','s':'Battegay','r':'ND'},{'n':'E','s':'Bernasconi','r':'ND'},{'n':'J','s':'Borovicka','r':'ND'},{'n':'S','s':'Colombo','r':'ND'},{'n':'A','s':'Cerny','r':'ND'},{'n':'JF','s':'Dufour','r':'ND'},{'n':'H','s':'Furrer','r':'ND'},{'n':'HF','s':'G\u00fcnthard','r':'ND'},{'n':'M','s':'Heim','r':'ND'},{'n':'B','s':'Hirschel','r':'ND'},{'n':'R','s':'Malinverni','r':'ND'},{'n':'D','s':'Moradpour','r':'ND'},{'n':'B','s':'M\u00fcllhaupt','r':'ND'},{'n':'A','s':'Witteck','r':'ND'},{'n':'JS','s':'Beckmann','r':'ND'},{'n':'T','s':'Berg','r':'ND'},{'n':'S','s':'Bergmann','r':'ND'},{'n':'F','s':'Negro','r':'ND'},{'n':'A','s':'Telenti','r':'ND'},{'n':'PY','s':'Bochud','r':'ND'}],'31':'138','64':'2010','65':'2010','14':{'f':'1338','l':'1338'},'118':'30'},{'071':'','012':{'t':'Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infection','l':'en'},'30':'Genes Immun','10':[{'n':'SL','s':'Rhodes','r':'ND'},{'n':'H','s':'Erlich','r':'ND'},{'n':'KA','s':'Im','r':'ND'},{'n':'J','s':'Wang','r':'ND'},{'n':'J','s':'Li','r':'ND'},{'n':'T','s':'Bugawan','r':'ND'},{'n':'L','s':'Jeffers','r':'ND'},{'n':'X','s':'Tong','r':'ND'},{'n':'X','s':'Su','r':'ND'},{'n':'HR','s':'Rosen','r':'ND'},{'n':'LJ','s':'Yee','r':'ND'},{'n':'TJ','s':'Liang','r':'ND'},{'n':'H','s':'Yang','r':'ND'}],'31':'9','64':'2008','65':'2008','14':{'f':'328','l':'328'},'118':'31'},{'071':'','012':{'t':'Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C','l':'en'},'30':'Hepatology','10':[{'n':'BC','s':'Smith','r':'ND'},{'n':'J','s':'Gorve','r':'ND'},{'n':'MA','s':'Guzail','r':'ND'},{'n':'CP','s':'Day','r':'ND'},{'n':'AK','s':'Daly','r':'ND'},{'n':'AD','s':'Burt','r':'ND'},{'n':'MF','s':'Bassendine','r':'ND'}],'31':'27','64':'1998','65':'1998','14':{'f':'1695','l':'1695'},'118':'32'},{'071':'','012':{'t':'Effect of iron overload on the severity of liver histologic alterations and on the response to interferon and ribavirin therapy of patients with hepatitis C infection','l':'en'},'30':'Braz J Med Biol Res','10':[{'n':'RM','s':'Souza','r':'ND'},{'n':'LA','s':'Freitas','r':'ND'},{'n':'AC','s':'Lyra','r':'ND'},{'n':'CF','s':'Moraes','r':'ND'},{'n':'EL','s':'Braga','r':'ND'},{'n':'LG','s':'Lyra','r':'ND'}],'31':'39','64':'2006','65':'2006','14':{'f':'79','l':'79'},'118':'33'},{'071':'','012':{'t':'Gamma delta intraepithelial lymphocytes drive tumor necrosis factor-alpha responsiveness to intestinal iron challenge: relevance to hemochromatosis','l':'en'},'30':'Immunol Rev','10':[{'n':'AE','s':'Ten Elshof','r':'ND'},{'n':'GM','s':'Brittenham','r':'ND'},{'n':'KA','s':'Chorney','r':'ND'},{'n':'MJ','s':'Page','r':'ND'},{'n':'G','s':'Gerhard','r':'ND'},{'n':'EE','s':'Cable','r':'ND'},{'n':'MJ','s':'Chorney','r':'ND'}],'31':'167','64':'1999','65':'1999','14':{'f':'223','l':'223'},'118':'34'},{'071':'','012':{'t':'The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C','l':'en'},'30':'Gut','10':[{'n':'D','s':'Thorburn','r':'ND'},{'n':'G','s':'Curry','r':'ND'},{'n':'R','s':'Spooner','r':'ND'},{'n':'E','s':'Spence','r':'ND'},{'n':'K','s':'Oien','r':'ND'},{'n':'D','s':'Halls','r':'ND'},{'n':'R','s':'Fox','r':'ND'},{'n':'EA','s':'McCruden','r':'ND'},{'n':'RN','s':'MacSween','r':'ND'},{'n':'PR','s':'Mills','r':'ND'}],'31':'50','64':'2002','65':'2002','14':{'f':'248','l':'248'},'118':'35'},{'071':'','012':{'t':'Prognostic effect of human leukocyte antigen class I and II alleles on chronic hepatitis C patients treated by pegylated interferon-alfa plus ribavirin in Taiwan','l':'en'},'30':'Hepatogastroenterology','10':[{'n':'KC','s':'Tseng','r':'ND'},{'n':'CK','s':'Chang','r':'ND'},{'n':'AL','s':'Chou','r':'ND'},{'n':'YH','s':'Hsieh','r':'ND'},{'n':'CA','s':'Tseng','r':'ND'},{'n':'NS','s':'Lai','r':'ND'}],'31':'57','64':'2010','65':'2010','14':{'f':'456','l':'456'},'118':'36'},{'071':'','012':{'t':'Hepatitis C, iron status, and disease severity: relationship with HFE mutations','l':'en'},'30':'Gastroenterology','10':[{'n':'BY','s':'Tung','r':'ND'},{'n':'MJ','s':'Emond','r':'ND'},{'n':'MP','s':'Bronner','r':'ND'},{'n':'SD','s':'Raaka','r':'ND'},{'n':'SJ','s':'Cotler','r':'ND'},{'n':'KV','s':'Kowdley','r':'ND'}],'31':'124','64':'2003','65':'2003','14':{'f':'318','l':'318'},'118':'37'}]}}"
0004-2803-ag-49-01-0005.id
0004-2803-ag-49-1-1.id
0004-2803-ag-49-1-19.id
0004-2803-ag-49-1-35.id
0004-2803-ag-49-1-41.id
0004-2803-ag-49-1-5.id
0004-2803-ag-49-1-52.id
0004-2803-ag-49-1-89.id
0004-2803-ag-49-1-9.id
0004-2803-ag-49-19.id
0004-2803-ag-49-28.id
0004-2803-ag-49-5.id
0004-2803-ag-49-56.id
0004-2803-ag-49-77.id
0004-2803-ag-49-82.id
0004-2803-ag-49-9.id
id2mst.bat
temp.mst
temp.xrf
v49n1.bat
v49n1.log
v49n1.mst
v49n1.sh
v49n1.xrf
